BOSTON (Oct. 24, 2024) – Anaphylaxis can come on suddenly and without warning, and because its symptoms can be fatal, it is scary for those who encounter it. Two new studies being presented at this ...

Misinformation and outdated protocols contribute to the suboptimal management of anaphylaxis by patients and healthcare professionals, based on data from two new studies presented at the American ...

Approximately 2% of adults and 4% to 8% of children have food allergies in the U.S., with food-induced anaphylaxis resulting in roughly 30,000 emergency department visits, 2,000 hospitalizations, and ...

An international panel of experts has developed standardized definitions and treatment protocols for anaphylaxis, aiming to eliminate long-standing inconsistencies in emergency care. The Global ...

“Outdated protocols” and a lack of patient education around anaphylaxis treatment can result in poor patient outcomes, Medscape Medical News reported Oct. 28. A survey of 96 patients and caregivers ...

Please provide your email address to receive an email when new articles are posted on . Omalizumab may effectively treat idiopathic anaphylaxis in patients without indication of mast cell clonality ...

Neffy, a nasal spray alternative to the EpiPen and similar injectables, has been approved by the FDA. The first-ever needle-free alternative to the EpiPen and similar epinephrine autoinjectors has ...

ARS Pharma had high hopes that the FDA on Tuesday would approve its flagship product, a needle-free treatment for adults and children with severe allergic reactions. But instead, the drugmaker was set ...

ARLINGTON HEIGHTS, Ill. – (December 18, 2023) — Two new practice parameters from the Joint Task Force for Practice Parameters (JTFPP) offer evidence-based recommendations for the diagnosis and ...

Anaphylaxis is a severe, life threatening allergic reaction; but now, there are new recommendations on how to improve treatment. Anaphylaxis can progress quickly and could be deadly if the life-saving ...

Two new practice parameters from the Joint Task Force for Practice Parameters (JTFPP) offer evidence-based recommendations for the diagnosis and management of anaphylaxis and atopic dermatitis (AD) in ...

Dr. F. Dan Atkins answers the question: 'How Is Anaphylaxis Treated?' — -- Question: How is anaphylaxis treated? Answer: Any patient with a history of anaphylaxis needs an anaphylaxis action plan ...